Efficacy of Postoperative Concurrent Chemoradiation for Resectable Rectal Cancer: A Single Institute Experience-Reference-Cited by-同舟云学术

Efficacy of Postoperative Concurrent Chemoradiation for Resectable Rectal Cancer: A Single Institute Experience

Published:2004 Issue:4 Volume:36 Page:228
ISSN:1598-2998
Container-title:Cancer Research and Treatment
language:en
Short-container-title:Cancer Res Treat

Author:

Ahn Joong Bae¹,Chung Hee Chul²,Yoo Nae Choon³²,Roh Jae Kyung³²,Kim Nam Kyu⁴,Suh Chang Ok⁵,Kim Gwi Eon⁵,Seong Jin Sil⁵,Shim Woong Ho⁶,Chung Hyun Cheol³²

Affiliation:

1. Center for Colorectal Cancer, National Cancer Center, Gyeonggi-do, Korea.

2. Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.

3. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

4. Department of General Surgery, Yonsei University College of Medicine, Seoul, Korea.

5. Department of Radiation Oncology, Yonsei University College of Medicine, Seoul, Korea.

6. Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

Publisher

Korean Cancer Association

Subject

Cancer Research,Oncology

Link

http://www.e-crt.org/upload/pdf/crt-36-228.pdf

Reference21 articles.

1. Patterns of pelvic recurrence following definitive resections of rectal cancer

2. Patterns of recurrence in adenocarcinoma of the rectum and rectosigmoid treated with surgery alone: Implications in treatment planning with adjuvant radiation therapy

3. Prolongation of the Disease-Free Interval in Surgically Treated Rectal Carcinoma

4. Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Is the Prognostic Value of the (Y)pN Status After Chemoradiotherapy in Rectal Cancer?;Multidisciplinary Management of Rectal Cancer;2018

2. A 19-Gene expression signature as a predictor of survival in colorectal cancer;BMC Medical Genomics;2016-09-08

3. Seven low-mass ions in pretreatment serum as potential predictive markers of the chemoradiotherapy response of rectal cancer;Anti-Cancer Drugs;2016-09

4. Safety of Early Chemotherapy after a Laparoscopic Colorectal Cancer Resection: A Case-Control Study;Journal of the Korean Society of Coloproctology;2009